19 Recruiting Atopic Dermatitis Clinical Trials in California
Explore active atopic dermatitis research studies enrolling across California. Verify eligibility and contact site coordinators.
📍 Find Near Me by DistanceBrowse by City
Recruiting Atopic Dermatitis Studies in California
A Study Evaluating APG777 in Atopic Dermatitis
📍 Investigational Site — Fountain Valley, California
View Study & Checklist ➔A Study to Assess the Efficacy and Safety of Afimkibart (RO7790121) in Participants With Moderate to Severe Atopic Dermatitis
📍 The Center for Dermatology Clinical Research — Fremont, California
View Study & Checklist ➔A Study Evaluating TRIV-509 in Atopic Dermatitis
📍 Triveni Bio Site #11 — Fountain Valley, California
View Study & Checklist ➔Phase 2a Study to Assess the Efficacy,Safety and Tolerability of GIA632 in Adult Participants With Moderate to Severe Atopic Dermatitis
📍 Ctr for Dermatology Clinical Res — Fremont, California
View Study & Checklist ➔Investigating Participation Patterns of Patients in Atopic Dermatitis Clinical Trials
📍 Power Life Sciences — San Francisco, California
View Study & Checklist ➔A Phase 2b Dose-Ranging Study to Evaluate the Efficacy and Safety of ENV-294 in Adults With Moderate-to-Severe Atopic Dermatitis
📍 Enveda Investigative Site — Encinitas, California
View Study & Checklist ➔A Long Term Extension Study to Evaluate the Safety and Efficacy of Afimkibart (RO7790121) in Participants With Atopic Dermatitis
📍 UCLA Division of Dermatology — Los Angeles, California
View Study & Checklist ➔A Long-term Safety and Efficacy Study Evaluating APG777 in Atopic Dermatitis
📍 Investigational Site — Fountain Valley, California
View Study & Checklist ➔Molecular Signatures of Cutaneous Dupilumab Response
📍 University of California, San Francisco — San Francisco, California
View Study & Checklist ➔A Study to Evaluate the Efficacy and Safety of IMG-007 in Adult Participants With Moderate-to-Severe Atopic Dermatitis
📍 Inmagene Site 1 — Lancaster, California
View Study & Checklist ➔Targeted Investigation of Microbiome 2 Treat Atopic Dermatitis (TIME-2)
📍 University of California, San Diego: Dermatology Clinical Trials Unit — San Diego, California
View Study & Checklist ➔A Study of BBT001 in Healthy Volunteers (HVs) and in Adult Patients With Atopic Dermatitis (AD)
📍 First OC Dermatology — Irvine, California
View Study & Checklist ➔Evaluate Efficacy and Safety of Repeat Subcutaneous Doses of FB825 in Adults With Moderate-to-Severe Atopic Dermatitis
📍 First OC Dermatology — Fountain Valley, California
View Study & Checklist ➔Study to Evaluate Soquelitinib in Participants With Moderate to Severe AD
📍 Corvus Clinical Trials — South San Francisco, California
View Study & Checklist ➔Real World Efficiency of Abrocitinib Treatment at Patients With Moderate to Severe Atopic Dermatitis Who Had Inadequate Response to Previous Biologic Therapies.
📍 Allergy and Asthma Medical Group and Research Center — San Diego, California
View Study & Checklist ➔A Dose-ranging Study to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Galvokimig in Adult Study Participants With Atopic Dermatitis
📍 Atd002 52021 — Oceanside, California
View Study & Checklist ➔A Study to Learn About Study Medicine Called PF-08049820 in People With Eczema
📍 Marvel Clinical Research — Huntington Beach, California
View Study & Checklist ➔Lebrikizumab in Moderate-to-severe Atopic Dermatitis
📍 Physioseq USA - CA — Folsom, California
View Study & Checklist ➔Monitoring Pregnancy and Infant Outcomes Following Tralokinumab Exposure During Pregnancy in the US and Canada - PROTECT
📍 University of California San Diego (UCSD) — La Jolla, California
View Study & Checklist ➔